TNFRSF4 and non-small cell lung carcinoma: In another study, high OX40 in tumor immune infiltrate was found to have a favorable prognosis in patients with stage I-III NSCLC (n = 100), but authors did not specify the subset of T cells with high OX40 expression [36].